Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.

Investing.com -- UBS upgraded Philip Morris International (NYSE: PM) to Neutral from Sell on a stronger-than-expected ...

AbbVie stock rose after the pharmaceutical company reported quarterly earnings that beat analysts’ expectations and raised ...